Critical outcomes | |||||||||||
Trial ID | Study follow‐up (in days) |
TZ n |
Standard of care or Placebo n |
All‐cause mortality | Clinical improvement | WHO SCORE 7 and above | AE | SAE | |||
Day 28 | Day ≥60 | Day 28 | Day ≥60 | Day 28 | Day ≥60 | ||||||
Rosas COVACTA 2021 | 60 | 301 | 151 | ✓ | * | * | * | ✓ | * | ✓ | ✓ |
Wang 2020 | 14 | 33 | 32 | X | * | * | * | ✓ | * | ✓ | ✓ |
Hermine CORIMUNO‐19 2020 | 90 | 64 | 67 | ✓ | ✓ | ✓ | * | ✓ | * | ✓ | ✓ |
Salvarani 2020 | 30 | 60 | 66 | ✓ | * | ✓ | * | * | * | ✓ | ✓ |
Stone 2020 | 28 | 161 | 82 | ✓ | * | ✓ | * | * | * | ✓ | ✓ |
Salama EMPACTA 2020 | 60 | 259 | 129 | ✓ | ✓ | * | * | * | * | ✓ | ✓ |
Gordon REMAP‐CAP 2021 | 90 | 48 | 412 | ✓ | * | * | * | * | * | * | ✓ |
Horby RECOVERY 2021 | 28 | 2022 | 2094 | ✓ | * | ✓ | * | ✓ | * | * | * |